Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2017 - 07 - 05
点击次数: 0
Positions: Vice President, Business Development
Company: Innovent Biologics, Inc.
个人简介:
Blake Salisbury currently leads BD activities as the VP of Business Development at Innovent Biologics, a China based innovative biopharmaceutical company.  Blake has 25 years of experience in pharma/biotech, primarily in business development (18 years), but also in sales, marketing, and pricing. Blake spent almost 24 years with Eli Lillyand Company where he closed over 50 transactions of various types, many of which were notable transactions with Chinese companies, starting as early as 2006.Blake’s last position at Lilly was as a Senior Director of Corporate Business Development – responsible for in-license, out-license, and M&A activities supporting Lilly’s various Business Units. Also while at Lilly, Mr. Salisbury led business development transactions sponsored by Lilly’s emerging markets business unit and forLilly Research Labsrelated to research and technology licensing activities.
发布时间: 2017 - 06 - 15
点击次数: 0
Positions: CEO / CSO
Company: BIRD-C GmbH & Co KG
个人简介:
Werner Lubitz , born in Wels, Austria, holds an MSc and a PhD in Microbiology from the Technical University of Munich, Germany. He obtained his postdoctoral training in Cell- and Tumor-Biology at the Institute of Cell Biology, University of Munich, Germany, at the Centre Hopitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, at the Wallenberg Laboratories, University of Uppsala, Sweden, at the Biocenter, University of Basel, Switzerland, and at the Max Plank Institute of Neurobiology, Martinsried, Germany, and in Genetic Engineering and Microbiology at the Institute of Microbiology, University of Victoria, Canada. Werner Lubitz was Associate Professor of Microbiology at the Institute of Microbiology, University of Kaiserslautern, Germany, and Associate Professor at the Institute of Genetics, University of Munich, Germany. Since 1987, he was Full Professor of Microbiology and Biotechnology at the University of Vienna, Austria, first at the Department of Microbiology, Genetics and Immunology, later at the Department of Medicinal Chemistry, University of Vienna, and the Center of Molecular Biology, Vienna Biocenter. He published more than 200 peer reviewed papers and holds an extensive patent portfolio. Werner Lubitz is the inventor of the Bacterial Ghost Platform Technology He is the founder and cofounder of three Biotech Companies and after retirement from the University of Vienna, 2010, he is the CEO of BIRD-C.
发布时间: 2017 - 06 - 15
点击次数: 0
Positions: Chairman and expert
Company: Tongxieyi, New Drug Elite Club
个人简介:
医学博士,著名免疫学家,国家新药咨询委员,国家自然科学基金专家组成员,吉林大学教授,博士生导师,同写意新药英才俱乐部理事长。•  曾任白求恩医科大学副校长,长春市政府副秘书长,国泰国际医药公司常务副总经理等。 现兼任新天域资本、尚珹资本特聘医药专家,四环制药独立董事、国泰国际医药有限公司非执行董事、深圳奥萨医药高级顾问、绿叶制药顾问等。 •  •  参加国内多家医药产业园区及医药企业的战略咨询,技术及项目论证等数十次,曾担任多家医药公司的顾问。•  多次参加国务院研究发展中心、国家发改委、国家食品药品监督管理局、科技部等组织的咨询及论证会;应邀在国际及全国性会议或论坛上做大会报告或主题演讲(讲座)80余次;并多次组织或主持了全国性及区域性的“生物技术”研讨会或专题报告会。•  引荐、协助了20余名留学生回国创业或加盟国内制药公司,其中多家企业已经成为各自领域的行业龙头。•  调查了数百家医药及医药相关的公司,遍及全国20多个省份及北美湾区、大费城地区及大波士顿地区等;评价医药及生物技术公司及项目近千项。
发布时间: 2017 - 06 - 15
点击次数: 0
Positions: Senior Vice President
Company: CBA -The Chinese Biopharmaceutical Association-USA
个人简介:
Dr. Shou-Bai Chao is currently Senior Vice President leading AstraZeneca's BioVentures Operations globally and specifically in China and other asian countries. The AZ BioVentures business is newly established within AZ reporting directly to the CEO. Dr. Chao will lead a dedicated team to develop Biosimilars with leading biotech companies in China and other Asian countries for the global markets. Dr. Chao is relocated to Shanghai AZ headquarter.
42页次10/11首页Previous...  234567891011Next尾页